Equities Analysts Offer Predictions for Celsius Q1 Earnings

Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Equities research analysts at Roth Capital cut their Q1 2025 earnings per share (EPS) estimates for Celsius in a research report issued to clients and investors on Friday, April 25th. Roth Capital analyst S. Mcgowan now forecasts that the company will earn $0.17 per share for the quarter, down from their prior estimate of $0.21. The consensus estimate for Celsius' current full-year earnings is $0.89 per share.

A number of other research firms also recently issued reports on CELH. Needham & Company LLC increased their price objective on Celsius from $40.00 to $45.00 and gave the stock a "buy" rating in a report on Wednesday, April 9th. LADENBURG THALM/SH SH decreased their price objective on Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Truist Financial raised shares of Celsius from a "hold" rating to a "buy" rating and increased their price objective for the company from $35.00 to $45.00 in a research report on Monday, March 31st. TD Cowen downgraded shares of Celsius from a "buy" rating to a "hold" rating and dropped their target price for the stock from $40.00 to $29.00 in a research note on Wednesday, January 22nd. Finally, UBS Group upped their target price on shares of Celsius from $43.00 to $48.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $46.47.

Celsius Stock Performance

Shares of Celsius stock traded down $0.16 during midday trading on Monday, reaching $34.80. 1,815,479 shares of the company's stock traded hands, compared to its average volume of 7,797,470. The company has a market cap of $8.97 billion, a PE ratio of 79.02, a price-to-earnings-growth ratio of 2.90 and a beta of 1.58. The stock has a 50 day moving average of $32.84 and a 200-day moving average of $29.58. Celsius has a 12 month low of $21.10 and a 12 month high of $98.85.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.03. The firm had revenue of $332.20 million during the quarter, compared to analyst estimates of $326.07 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%.

Institutional Trading of Celsius

Hedge funds and other institutional investors have recently modified their holdings of the company. HM Payson & Co. increased its stake in shares of Celsius by 122.2% in the fourth quarter. HM Payson & Co. now owns 1,000 shares of the company's stock worth $26,000 after purchasing an additional 550 shares in the last quarter. Westside Investment Management Inc. purchased a new stake in shares of Celsius in the first quarter worth $32,000. S.A. Mason LLC increased its stake in shares of Celsius by 100.0% in the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock worth $37,000 after purchasing an additional 700 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in shares of Celsius by 255.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after purchasing an additional 750 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of Celsius by 185.7% in the fourth quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock worth $45,000 after purchasing an additional 1,114 shares in the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Celsius

In other Celsius news, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the completion of the sale, the insider now directly owns 45,297 shares of the company's stock, valued at approximately $1,167,303.69. This represents a 18.36 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Joyce Russell sold 4,000 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the sale, the director now directly owns 19,106 shares of the company's stock, valued at approximately $543,947.82. This represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.